AXA FRAMLINGTON BIOTECH FUND

2138003S7OCTPN98LK47

The entity

Status: Active
LEI status: Issued and current
Category: Fund
Legal form: 8888
Jurisdiction: United Kingdom
Entity created: October 24, 2001

Address

Country: United Kingdom
Legal address: C/O AXA INVESTMENT MANAGERS UK LIMITED, 22 BISHOPSGATEEC2N 4BQ LONDONUnited Kingdom (GB-LND)

Identifier

LEI: 2138003S7OCTPN98LK47
Registered: September 11, 2017 at 12:00 AM UTC
Last updated: July 29, 2026 at 03:44 PM UTC
Next renewal: September 11, 2027 at 12:00 AM UTC
Issuer: London Stock Exchange (213800WAVVOPS85N2205)
Registered with: Financial Services Register (RA000592)
Identifier: 196896
Verified against: Financial Services Register (RA000592)
Verified as: 196896
Corroboration: Confirmed against a public register
GLEIF conformity: Meets the standard

Corporate structure

Owned by

AXA
Direct parent · Ultimate parentFranceF5WCUMTUM4RKZ1MAIE39
AXA INVESTMENT MANAGERS UK LIMITED
Fund managerUnited Kingdom213800PZDUGEXMRMKR15

Machine access

REST: https://lei.online/v1/entities/2138003S7OCTPN98LK47This record as JSON.
MCP: https://lei.online/mcpThe same data as an MCP tool.

Start a new search